Why Docrates?
Docrates Cancer Center delivers high quality and prompt cancer care. We provide personalized diagnostics and the latest cancer treatments without delay. We cherish a good quality of life and care for the patient as a whole. We welcome patients from all over the world.
Individuality
High quality care
Speed
Read our patients' stories
Hannu Nurmio: Aiming for a normal everyday life
When rock musician Hannu "Tuomari" Nurmio, 73, learned that his PSA values were elevated, he decided to go for an...
Read more“It feels wonderful to not have cancer anymore”
Pirjo, 75, has had breast cancer twice. She credits both her spouse Timo and the professionals at Docrates for the...
The story of a breast cancer patient: You have to focus on the good things, even if the world keeps spinning
It is December, and the first long year of the pandemic is nearing its end. A couple is sitting in...
Cancer diagnosis did not stop Mika Piltz: “I’m grateful that quality of life can be improved with the right treatment methods”
Getting diagnosed with prostate cancer turned the world of Mika Piltz, 54, upside down in 2021. His calendar was filled...
Competence in different types of cancer
Our experts have extensive knowledge of the diagnosis and treatment of various cancers.
On our website you will find the latest information on various cancers, diagnostics and treatment options.
The most common forms of cancer
News and articles
Breast reconstruction surgery means meticulous craftsmanship by experienced surgeons
Reconstructing a removed breast is part of the treatment path of many breast cancer patients. The goal of the surgery...
Chief Clinical Director of Docrates Cancer Center: “Genetic information is an essential part of modern cancer care”
New forms of treatment based on molecular diagnostics enable more and more patients to completely recover from cancer, and make...
Customer message 3. September, 2024
With a transaction signed on 2 September 2024, Mehiläinen has acquired Docrates Ltd, as a result of which Docrates Cancer...
The competition authority issues its decision on the merger of Mehiläinen and Docrates Cancer Center
On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....